Search

Embecta Corp

Закрыт

СекторЗдравоохранение

4.42 26.65

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

3.51

Макс.

4.68

Ключевые показатели

By Trading Economics

Доход

-48M

-4.1M

Продажи

-39M

222M

P/E

Средняя по отрасли

1.928

68.51

Прибыль на акцию

0.27

Дивидендная доходность

16.48

Рентабельность продаж

-1.849

Сотрудники

1,850

EBITDA

-51M

45M

Рекомендации

By TipRanks

Рекомендации

Продажа

Прогноз на 12 месяцев

-14.29% downside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

16.48%

2.29%

Следующий отчет о доходах

7 авг. 2026 г.

Дата следующей выплаты дивидендов

15 сент. 2026 г.

Следующая эксдивидендная дата

27 авг. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-327M

221M

Предыдущая цена открытия

-22.23

Предыдущая цена закрытия

4.42

Новостные настроения

By Acuity

72%

28%

308 / 340 Рейтинг в Healthcare

Embecta Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

6 авг. 2026 г., 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5 авг. 2026 г., 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4 авг. 2026 г., 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3 авг. 2026 г., 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31 июл. 2026 г., 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30 июл. 2026 г., 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29 июл. 2026 г., 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28 июл. 2026 г., 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27 июл. 2026 г., 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24 июл. 2026 г., 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22 июл. 2026 г., 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21 июл. 2026 г., 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20 июл. 2026 г., 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Сравнение c конкурентами

Изменение цены

Embecta Corp Прогноз

Целевая цена

By TipRanks

-14.29% падение

Прогноз на 12 месяцев

Средняя 3 USD  -14.29%

Максимум 3 USD

Минимум 3 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Embecta Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Продажа

2 ratings

0

Покупка

1

Удержание

1

Продажа

Настроения

By Acuity

308 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat